CAS 934353-76-1
:ENMD-2076
Description:
ENMD-2076, with the CAS number 934353-76-1, is a small molecule that has been investigated primarily for its potential therapeutic applications, particularly in the field of oncology. It is classified as a selective inhibitor of certain kinases, which play crucial roles in cell signaling pathways that regulate cell growth and proliferation. The compound has shown promise in preclinical studies for its ability to inhibit tumor growth and induce apoptosis in cancer cells. ENMD-2076 is characterized by its specific binding affinity to target kinases, which may contribute to its efficacy in disrupting cancer cell signaling. Additionally, it has been evaluated for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are essential for determining its suitability as a therapeutic agent. As with many investigational drugs, ongoing research aims to further elucidate its mechanism of action, optimize its formulation, and assess its safety and effectiveness in clinical settings.
Formula:C21H25N7
InChI:InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+
InChI key:BLQYVHBZHAISJM-CMDGGOBGSA-N
SMILES:CC1=CC(=NN1)NC2=CC(=NC(=N2)/C=C/C3=CC=CC=C3)N4CCN(CC4)C
Synonyms:- ENMD-2076 (Tartrate)
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
ENMD-2076
CAS:ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRα.Formula:C21H25N7Purity:97.63% - 99.86%Color and Shape:SolidMolecular weight:375.4701ENMD-2076
CAS:(E)-N-(5-Methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amineFormula:C21H25N7Purity:98%Molecular weight:375.47
